Saltar al contenido principal
xMedica

NCT06378632ClinicalTrials.gov

AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM

An International Multi-center Observational, Single-arm, Blinded Study to Assess the Performance of the Cordio HearO System

En reclutamientoAdmite participantes ahora, según el registro.
Contactar con este estudio

En resumen

Study Design: This is an international, multicenter, observational, non-interventional, prospective, blinded, single-arm, two-period study, to collect patient utterances that will be retrospectively analyzed to determine the sensitivity and UPNR of the HearO system.

Observacional500 participantes buscados45 centros3 países

Categorías

Registrado en 1 registro

Un mismo estudio puede estar registrado en varios registros. Lo mostramos una sola vez y enlazamos con todos los registros que tenemos.

La información del ensayo se muestra tal como la publicó el registro, en su idioma original.

¿Le interesa este estudio?

Iniciar sesión o cree una cuenta para registrar su interés y seguir este estudio.

How this study is set up

The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.

  • Not stated: Registered after enrolment began (about 801 days after the recorded start)First posted 2024-04-22; recorded start 2022-02-11
  • Present: Has a defined primary outcomeA primary outcome measure is listed in the record
  • Present: The primary outcome states a time frameThe primary outcome measure records a time frame
  • Not stated: Whether participants are randomly assigned is not stated in the registry recordNo allocation method is recorded
  • Not stated: Whether there is a comparison group is not stated in the registry recordThe record does not describe the study arms
  • Not stated: Whether the study is blinded is not stated in the registry recordNo masking information is recorded
  • Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
  • Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
  • Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
  • Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
  • Present: Sponsor has 1 other study in this databaseCounted from the lead sponsor named in the record (Cordio Medical)
  • Not stated: No posted results from this sponsor are in this database yetBased on the sponsor’s studies in this database
  • The record lists 1 condition.
  • Lead sponsor type recorded as: industry.

Trial stature

Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.

Methodological rigourEXPLORATORY

An exploratory-stage design for a study of this type, judged from its ClinicalTrials.gov record.

How this score is built
  • Randomised allocation0/20

    Allocation not stated in the record

  • Blinding0/20

    Masking not stated in the record

  • Control arm0/15

    No comparator arm stated in the record

  • Primary-outcome specificity10/10

    Named primary outcome with a defined time frame

  • Endpoint type7/10

    Clinical-event endpoint

  • Multi-centre8/8

    Multi-centre: 45 sites

  • Data monitoring committee0/7

    No data monitoring committee stated

  • Prospective registration0/5

    Registered more than 30 days after the study start

  • Protocol / SAP posted0/5

    No protocol or SAP posted to the registry

ScaleMEDIUM

A medium-sized study, international in scope: 500 participants (target), run at 45 sites, across 3 countries.

How this score is built
  • Enrolment26/40

    500 participants (target)

  • Site count19/25

    45 sites

  • Country count7/15

    3 countries

  • Planned duration8/10

    Planned over about 42 months

  • Sponsor scale1/10

    Cordio Medical has led 2 trials in our corpus

Investigator standingUNKNOWN

We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.

How this score is built
  • Investigator standing0/100

    No investigator recorded in the registry for this trial

These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.

Resumen

Study Design: This is an international, multicenter, observational, non-interventional, prospective, blinded, single-arm, two-period study, to collect patient utterances that will be retrospectively analyzed to determine the sensitivity and UPNR of the HearO system.

Two periods: Run-In period will be a period in which patients will submit daily recordings, baseline creation Core period will be a period in which patients will be followed up and will continually submit daily recordings for up-to 24 months per patient or until End-of-Study (EOS), whichever comes first.

Afecciones

  • Heart Failure

Elegibilidad

Elegibilidad
SexoTodos
Edades22 YearsSin máximo
Voluntarios sanosNo
Método de muestreoNON_PROBABILITY_SAMPLE

Población del estudio

Outpatient clinics

Elegibilidad tal como figura en el registro

Major Inclusion Criteria: 1. Age 22 or greater 2. Diagnosed with Symptomatic Chronic Heart Failure \[NYHA II-IVa (ambulatory)\] 3. At least one of the following: 1. One ADHF hospitalization in the last 12 months 2. One unplanned IV/SC diuretic administration in the last 6 months 3. Two unplanned IV/SC diuretic administrations in the last 12 months 4. NTProBNP \>500 pg/ml 4. Clinically stable HF according to investigator discretion 5. Willing to participate as evidenced by signing the written informed consent. Major Exclusion Criteria: 1. Unable to comply with daily use of the App, 2. Has had a major cardiovascular event within 3 months prior to enrolment. 3. Had a Cardiac Resynchronization Therapy Device (CRT) implanted or upgrading ≤ 1 month prior to screening visit. 4. Has estimated Glomerular Filtration Rate (eGFR) \< 30 ml/min/1.73. 5. Is likely to undergo heart transplantation/ LVAD within 6 months of Screening Visit. 6. Was treated for a significant COPD

Elegibilidad en frases sencillas

Los criterios de este registro aún no se han desglosado en frases separadas. El texto del registro anterior está completo y es la versión autorizada.

Diseño del estudio

Diseño del estudio
Tipo de estudioObservacional
FaseNo indicado en el registro
AsignaciónNo indicado en el registro
Modelo de intervenciónNo indicado en el registro
Propósito principalNo indicado en el registro
EnmascaramientoNo indicado en el registro
Inscripción500 participantes buscados

Patrocinador y colaboradores

  • Cordio Medical Patrocinador

Intervenciones

  • Dispositivo Hearo App

    No intervention - only data collection

Variables de resultado

  1. Variable de resultado principal

    Heart Failure Events (HFEs)

    Until the end of the study, each participant will be assigned to one of the following event outcomes: 1. Having at least one protocol-defined Heart Failure Event (HFE) in the CORE period 2. Having no Heart Failure Event (HFE) during the entire CORE period

    Plazo EOS is defined as when a total of at least 78 first usable and CEC-adjudicated HFEs have occurred or up-to 24 months per patient

Fechas

Fechas
Fecha de inicio11 de febrero de 2022 (real)
Finalización principal1 de julio de 2025 (estimada)
Finalización15 de julio de 2025 (estimada)
Primera publicación22 de abril de 2024 (real)
Última actualización26 de marzo de 2025
Resultados publicadosNo indicado en el registro
Estado verificado por última vezmarzo de 2025

Real significa que el evento ocurrió. Estimada significa que el patrocinador lo prevé. Ambas cosas significan algo distinto.

Ubicaciones

45 centros están en reclutamiento

Israel

Israel
CentroCiudadEstado o regiónEstado
University Hospital Samson Assuta AshdodAshdodEn reclutamiento
Assuta Be'er Sheva Medical CenterBeershebaEn reclutamiento
Rambam Medical CenterHaifaEn reclutamiento
Shaare Zedek Medical CenterJerusalemEn reclutamiento
Galiee Medical CenterNahariyaEn reclutamiento
Tel Aviv Sourasky (Ichilov) Medical CenterTel AvivEn reclutamiento
Poriya Medical CenterTiberiasEn reclutamiento

Spain

Spain
CentroCiudadEstado o regiónEstado
Hospital Universitari Germans Trias i PujolBadalonaEn reclutamiento

United States

United States
CentroCiudadEstado o regiónEstado
Mission HospitalAshevilleNorth CarolinaEn reclutamiento
West Georgia CardiologyCarrolltonGeorgiaEn reclutamiento
University of ChicagoChicagoIllinoisEn reclutamiento
Advocate Illinois Masonic Medical CenterChicagoIllinoisEn reclutamiento
The Lindner Research Center at The Christ HospitalCincinnatiOhioEn reclutamiento
Cleveland ClinicClevelandOhioEn reclutamiento
The Ohio State UniversityColumbusOhioEn reclutamiento
Nature Coast Clinical ResearchCrystal RiverFloridaEn reclutamiento
Advocate Illinois Masonic Health CenterDowners GroveIllinoisEn reclutamiento
St. Elizabeth HealthcareEdgewoodKentuckyEn reclutamiento
Eastern Shore Research InstituteFairhopeAlabamaEn reclutamiento
Moses H. Cone Memorial HospitalGreensboroNorth CarolinaEn reclutamiento
Cardiovascular Institute of the SouthHoumaLouisianaEn reclutamiento
Jacksonville Center for Clinical ResearchJacksonvilleFloridaEn reclutamiento
UC San Diego HealthLa JollaCaliforniaEn reclutamiento
Cardiovascular Institute of the SouthLafayetteLouisianaEn reclutamiento
Nebraska Heart CenterLincolnNebraskaEn reclutamiento
VA Loma Linda Healthcare SystemLoma LindaCaliforniaEn reclutamiento
Rio Grande Regional HospitalMcAllenTexasEn reclutamiento
Baptist Health (Miami Cardiac & Vascular Institute)MiamiFloridaEn reclutamiento
Advance Medical Research Services Corp (AMRS)MiamiFloridaEn reclutamiento
Amavita Clinical ResearchMiamiFloridaEn reclutamiento
Midwest Cardiovascular CenterNapervilleIllinoisEn reclutamiento
Vanderbilt University Medical CenterNashvilleTennesseeEn reclutamiento
University Medical Center New OrleansNew OrleansLouisianaEn reclutamiento
Mount Sinai MorningsideNew YorkNew YorkEn reclutamiento
The Mount Sinai HospitalNew YorkNew YorkEn reclutamiento
VA Southern Nevada Healthcare SystemNorth Las VegasNevadaEn reclutamiento
Comprehensive Medical & Research CenterPlantationFloridaEn reclutamiento
St. Francis HospitalRoslynNew YorkEn reclutamiento
St. Johns Center for Clinical ResearchSaint AugustineFloridaEn reclutamiento
Methodist Hospital of San AntonioSan AntonioTexasEn reclutamiento
VA San DiegoSan DiegoCaliforniaEn reclutamiento
Kaiser Permanente San FranciscoSan FranciscoCaliforniaEn reclutamiento
University of California, San FranciscoSan FranciscoCaliforniaEn reclutamiento
Tampa General HospitalTampaFloridaEn reclutamiento
Robert J. Dole VA Medical CenterWichitaKansasEn reclutamiento

Documentos del estudio

No hay documentos enlazados en este registro.

Cambios a lo largo del tiempo

No se han registrado cambios desde que incorporamos este registro por primera vez.

Se registra un cambio cada vez que el patrocinador actualiza el registro. El estado, las fechas, la inscripción y los centros aparecen aquí a medida que cambian.